Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses

Journal of Virology

Volumn 71, Issue 1, 1997, Pages 299-306

  Wetzel, J Denise ^a   Chappell, James D ^a   Fogo, Agnes B ^a   Dermody, Terence S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REOVIRUS; VIRION; VIRUS ASSEMBLY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0031060541     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.1.299-306.1997     Document Type: Article

References (39)

1. Ahmed, R., W. M. Canning, R. S. Kauffman, A. H. Sharpe, J. V. Hallum, and B. N. Fields. 1981. Role of the host cell in persistent viral infection: coevolution of L cells and reovirus during persistent infection. Cell 25:325-332.
2. Ahmed, R., P. R. Chakraborty, A. F. Graham, R. F. Ramig, and B. N. Fields. 1980. Genetic variation during persistent reovirus infection: presence of extragenically suppressed temperature-sensitive lesions in wild-type virus isolated from persistently infected L cells. J. Virol. 34:383-389.
3. Ahmed, R., and B. N. Fields. 1982. Role of the S4 gene in the establishment of persistent reovirus infection in L cells. Cell 28:605-612.
4. Ahmed, R., and A. F. Graham. 1977. Persistent infections in L cells with temperature-sensitive mutants of reovirus. J. Virol. 23:250-262.
5. Ahmed, R., R. S. Kauffman, and B. N. Fields. 1983. Genetic variation during persistent reovirus infection: isolation of cold-sensitive and temperature-sensitive mutants from persistently infected L cells. Virology 131:71-78.
6. Ahmed, R., L. A. Morrison, and D. M. Knipe. 1996. Persistence of viruses, p. 219-249. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia.
7. Bassel-Duby, R., A. Jayasuriya, D. Chatterjee, N. Sonenberg, J. V. Maizel, Jr., and B. N. Fields. 1985. Sequence of reovirus haemagglutinin predicts a coiled-coil structure. Nature (London) 315:421-423.
8. Borsa, J., M. D. Sargent, P. A. Lievaart, and T. P. Copps. 1981. Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 111:191-200.
9. Borzakian, S., T. Couderc, Y. Barbier, G. Attal, I. Pelletier, and F. Colbere-Garapin. 1992. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology 186:398-408.
10. Brown, E. G., M. L. Nibert, and B. N. Fields. 1983. The L2 gene of reovirus serotype 3 controls the capacity to interfere, accumulate deletions and establish persistent infection, p. 275-287. In R. W. Compans and D. H. L. Bishop (ed.), Double-stranded RNA viruses. Elsevier Biomedical, New York.
11. Burstin, S. J., D. R. Spriggs, and B. N. Fields. 1982. Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology 117:146-155.
12. Canning, W. M., and B. N. Fields. 1983. Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells. Science 219:987-988.
13. Chang, C. T., and H. J. Zweerink. 1971. Fate of parental reovirus in infected cell. Virology 46:544-555.
14. Chen, W., and R. S. Baric. 1996. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J. Virol. 70:3947-3960.
15. Danis, C., T. Mabrouk, S. Garzon, and G. Lemay. 1993. Establishment of persistent reovirus infection in SC1 cells: absence of protein synthesis inhibition and increased level of double-stranded RNA-activated protein kinase. Virus Res. 2727:253-265.
16. Dermody, T. S., J. D. Chappell, J. G. Hofler, W. Kramp, and K. L. Tyler. 1995. Eradication of persistent reovirus infection from a B-cell hybridoma. Virology 212:272-276.
17. Dermody, T. S., M. L. Nibert, J. D. Wetzel, X. Tong, and B. N. Fields. 1993. Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J. Virol. 67:2055-2063.
18. Dermody, T. S., and A. Warner. Unpublished observations.
19. Furlong, D. B., M. L. Nibert, and B. N. Fields. 1988. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 62:246-256.
20. Kaplan, G., A. Levy, and V. R. Racaniello. 1989. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J. Virol. 63:43-51.
21. Kowalik, T. F., Y.-Y. Yang, and J. K.-K. Li. 1990. Molecular cloning and comparative sequence analyses of bluetongue virus S1 segments by selective synthesis of specific full-length DNA copies of dsRNA genes. Virology 177:820-823.
22. Levy, J. A., G. Henle, W. Henle, and B. A. Zajac. 1968. Effect of reovirus type 3 on cultured Burkitt's tumour cells. Nature (London) 220:607-608.
23. Lucia-Jandris, P., J. W. Hooper, and B. N. Fields. 1993. Reovirus M2 gene is associated with chromium release from mouse L cells. J. Virol. 67:5339-5345.
24. Mahy, B. W. J. 1985. Strategies of viral persistence. Br. Med. Bull. 41:50-55.
25. Matsuzaki, N., V. S. Hinshaw, B. N. Fields, and M. I. Greene. 1986. Cell receptors for the mammalian reovirus: reovirus-specific T-cell hybridomas can become persistently infected and undergo autoimmune stimulation. J. Virol. 60:259-266.
26. Montgomery, L. B., C. Y. Y. Kao, E. M. Verdin, C. Cahill, and E. Maratos-Flier. 1991. Infection of a polarized epithelial cell line with wild-type reovirus leads to virus persistence and altered cellular function. J. Gen. Virol. 72:2939-2946.
27. Nibert, M. L., J. D. Chappell, and T. S. Dermody. 1995. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved Σ1 protein. J. Virol. 69:5057-5067.
28. Nibert, M. L., T. S. Dermody, and B. N. Fields. 1990. Structure of the reovirus cell-attachment protein: a model for the domain organization of Σ1. J. Virol. 64:2976-2989.
29. Nibert, M. L., and B. N. Fields. 1992. A carboxy-terminal fragment of protein μ1/μ1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J. Virol. 66:6408-6418.
30. Nibert, M. L., D. B. Furlong, and B. N. Fields. 1991. Mechanisms of viral pathogenesis: distinct forms of reoviruses and their roles during replication in cells and host. J. Clin. Invest. 88:727-734.
31. Ross, J., J. Glelen, S. Packman, Y. Ikawa, and P. Leder. 1974. Globin gene expression in cultured erythroleukemic cells. J. Mol. Biol. 87:697-714.
32. Rubin, D. H., J. D. Wetzel, C. Dworkin, W. V. Williams, J. A. Cohen, and T. S. Dermody. 1992. Binding of type 3 reovirus by a domain of the Σ1 protein important for hemagglutination leads to infection of murine erythroleukemia cells. J. Clin. Invest. 90:2536-2542.
33. Sharpe, A. H., and B. N. Fields. 1983. Pathogenesis of reovirus infection, p. 229-285. In W. K. Joklik (ed.), The Reoviridae. Plenum Press, New York.
34. Silverstein, S. C., C. Astell, D. H. Levin, M. Schonberg, and G. Acs. 1972. The mechanism of reovirus uncoating and gene activation in vivo. Virology 47:797-806.
35. Sturzenbecker, L. J., M. Nibert, D. Furlong, and B. N. Fields. 1987. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61:2351-2361.
36. Taber, R., V. Alexander, and W. Whitford. 1976. Persistent reovirus infection of CHO cells resulting in virus resistance. J. Virol. 17:513-525.
37. Verdin, E. M., E. Maratos-Flier, J. L. Carpentier, and C. R. Kahn. 1986. Persistent infection with a nontransforming RNA virus leads to impaired growth factor receptors and response. J. Cell. Physiol. 128:457-465.
38. Virgin, H. W., IV, R. Bassel-Duby, B. N. Fields, and K. L. Tyler. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J. Virol. 62:4594-4604.
39. Virgin, H. W., IV, M. A. Mann, and K. L. Tyler. 1994. Protective antibodies inhibit reovirus internalization and uncoating by intracellular proteases. J. Virol. 68:6719-6729.